{
    "hands_on_practices": [
        {
            "introduction": "Effective clinical practice hinges on the ability to accurately interpret diagnostic tests. This exercise focuses on a foundational skill: translating a test's abstract performance metrics—sensitivity and specificity—into clinically meaningful probabilities like the Positive and Negative Predictive Values ($PPV$ and $NPV$). By working through a scenario involving a high-performance biomarker for rupture of membranes , you will apply Bayes' theorem to see how a test result modifies your initial clinical suspicion, providing a quantitative basis for ruling a diagnosis in or out.",
            "id": "4497552",
            "problem": "A clinician is evaluating a patient at term with suspected prelabor rupture of membranes (ROM). A point-of-care Placental Alpha Microglobulin-1 (PAMG-1) immunoassay is used. The test’s sensitivity is $0.98$ and specificity is $0.95$. The clinician estimates the pretest probability (prior probability) of true ROM to be $0.60$. Using only foundational definitions—sensitivity as $P(+\\mid D)$, specificity as $P(-\\mid \\neg D)$, prior probability as $P(D)$, and Bayes’ theorem—derive the positive predictive value (PPV), defined as $P(D\\mid +)$, and the negative predictive value (NPV), defined as $P(\\neg D\\mid -)$. Then compute their numerical values. Round both PPV and NPV to four significant figures and express each as a decimal (no percentage sign). Finally, interpret the clinical implications by explaining, in terms of expected counts per $100$ tested patients under the given prior probability, how many true positives, false positives, true negatives, and false negatives would be expected, and comment on how this affects rule-in versus rule-out decisions for ROM at term.",
            "solution": "The problem as stated is valid. It is scientifically grounded in the principles of biostatistics and clinical epidemiology, well-posed with all necessary information provided, and objective in its formulation. We will proceed with a formal derivation and calculation.\n\nLet $D$ denote the event that a patient has true prelabor rupture of membranes (ROM), and let $\\neg D$ denote the event that the patient does not have ROM. Let $+$ denote a positive test result from the Placental Alpha Microglobulin-1 (PAMG-1) immunoassay, and let $-$ denote a negative test result.\n\nThe problem provides the following givens:\n1.  The pretest probability, or prior probability, of ROM is $P(D) = 0.60$.\n2.  The sensitivity of the test, defined as the probability of a positive test given the presence of the condition, is $P(+\\mid D) = 0.98$.\n3.  The specificity of the test, defined as the probability of a negative test given the absence of the condition, is $P(-\\mid \\neg D) = 0.95$.\n\nFrom these givens, we can derive the probabilities of their complementary events:\n- The prior probability of not having ROM is $P(\\neg D) = 1 - P(D) = 1 - 0.60 = 0.40$.\n- The false negative rate, which is the probability of a negative test given the presence of the condition, is $P(-\\mid D) = 1 - P(+\\mid D) = 1 - 0.98 = 0.02$.\n- The false positive rate, which is the probability of a positive test given the absence of the condition, is $P(+\\mid \\neg D) = 1 - P(-\\mid \\neg D) = 1 - 0.95 = 0.05$.\n\nThe problem requires the derivation and calculation of two quantities:\n1.  The Positive Predictive Value (PPV), defined as the probability of having the condition given a positive test result, $P(D\\mid +)$.\n2.  The Negative Predictive Value (NPV), defined as the probability of not having the condition given a negative test result, $P(\\neg D\\mid -)$.\n\nWe will use Bayes' theorem for these derivations.\n\n**Derivation and Calculation of Positive Predictive Value (PPV)**\n\nBy definition, Bayes' theorem states:\n$$ \\text{PPV} = P(D\\mid +) = \\frac{P(+\\mid D) P(D)}{P(+)} $$\nThe denominator, $P(+)$, represents the total probability of a positive test result. It can be expanded using the law of total probability, summing over the mutually exclusive events $D$ and $\\neg D$:\n$$ P(+) = P(+\\mid D)P(D) + P(+\\mid \\neg D)P(\\neg D) $$\nSubstituting the derived expression for the false positive rate, $P(+\\mid \\neg D) = 1 - P(-\\mid \\neg D)$, we get:\n$$ P(+) = P(+\\mid D)P(D) + (1 - P(-\\mid \\neg D))(1 - P(D)) $$\nSubstituting this back into the formula for PPV yields the full symbolic expression:\n$$ \\text{PPV} = \\frac{P(+\\mid D) P(D)}{P(+\\mid D)P(D) + (1 - P(-\\mid \\neg D))(1 - P(D))} $$\nNow, we substitute the given numerical values:\n$$ \\text{PPV} = \\frac{(0.98)(0.60)}{(0.98)(0.60) + (0.05)(0.40)} $$\n$$ \\text{PPV} = \\frac{0.588}{0.588 + 0.020} = \\frac{0.588}{0.608} $$\n$$ \\text{PPV} \\approx 0.96710526... $$\nRounding to four significant figures, we get $\\text{PPV} = 0.9671$.\n\n**Derivation and Calculation of Negative Predictive Value (NPV)**\n\nSimilarly, using Bayes' theorem for NPV:\n$$ \\text{NPV} = P(\\neg D\\mid -) = \\frac{P(-\\mid \\neg D) P(\\neg D)}{P(-)} $$\nThe denominator, $P(-)$, represents the total probability of a negative test result. Expanding using the law of total probability:\n$$ P(-) = P(-\\mid \\neg D)P(\\neg D) + P(-\\mid D)P(D) $$\nSubstituting the derived expression for the false negative rate, $P(-\\mid D) = 1 - P(+\\mid D)$, we get:\n$$ P(-) = P(-\\mid \\neg D)(1 - P(D)) + (1 - P(+\\mid D))P(D) $$\nSubstituting this back into the formula for NPV yields the full symbolic expression:\n$$ \\text{NPV} = \\frac{P(-\\mid \\neg D) (1 - P(D))}{P(-\\mid \\neg D)(1 - P(D)) + (1 - P(+\\mid D))P(D)} $$\nNow, we substitute the given numerical values:\n$$ \\text{NPV} = \\frac{(0.95)(0.40)}{(0.95)(0.40) + (0.02)(0.60)} $$\n$$ \\text{NPV} = \\frac{0.38}{0.38 + 0.012} = \\frac{0.38}{0.392} $$\n$$ \\text{NPV} \\approx 0.96938775... $$\nRounding to four significant figures, we get $\\text{NPV} = 0.9694$.\n\n**Clinical Implications and Interpretation**\n\nTo interpret these results, consider a hypothetical cohort of $100$ patients who present with symptoms leading to a pretest probability of ROM of $P(D)=0.60$.\n\n-   **Number of patients with ROM:** $100 \\times P(D) = 100 \\times 0.60 = 60$ patients.\n-   **Number of patients without ROM:** $100 \\times P(\\neg D) = 100 \\times 0.40 = 40$ patients.\n\nWe now apply the test to these two groups:\n\n1.  **Among the $60$ patients with ROM:**\n    -   **True Positives (TP):** The number who correctly test positive.\n        $ \\text{TP} = 60 \\times P(+\\mid D) = 60 \\times 0.98 = 58.8 $\n    -   **False Negatives (FN):** The number who incorrectly test negative.\n        $ \\text{FN} = 60 \\times P(-\\mid D) = 60 \\times 0.02 = 1.2 $\n\n2.  **Among the $40$ patients without ROM:**\n    -   **True Negatives (TN):** The number who correctly test negative.\n        $ \\text{TN} = 40 \\times P(-\\mid \\neg D) = 40 \\times 0.95 = 38 $\n    -   **False Positives (FP):** The number who incorrectly test positive.\n        $ \\text{FP} = 40 \\times P(+\\mid \\neg D) = 40 \\times 0.05 = 2.0 $\n\nThe expected counts per $100$ patients are:\n-   **True Positives (TP):** $58.8$\n-   **False Positives (FP):** $2.0$\n-   **True Negatives (TN):** $38.0$\n-   **False Negatives (FN):** $1.2$\n\nThe total number of positive tests is $\\text{TP} + \\text{FP} = 58.8 + 2.0 = 60.8$. The total number of negative tests is $\\text{TN} + \\text{FN} = 38.0 + 1.2 = 39.2$.\n\n**Implications for Rule-In vs. Rule-Out Decisions:**\n\n-   **Rule-In Decision (Positive Test):** A positive result is used to \"rule in\" a diagnosis. The efficacy of this is measured by the PPV. Our calculated $\\text{PPV}$ is $0.9671$. This signifies that if a patient tests positive, there is a $96.71\\%$ probability that they truly have ROM. In our cohort of $100$, out of approximately $61$ positive tests ($60.8$), about $59$ ($58.8$) are true positives and only $2$ are false positives. This extremely high PPV makes the PAMG-1 test a powerful tool for confirming ROM. A clinician can be highly confident in the diagnosis and proceed with appropriate management (e.g., admission, consideration for induction of labor).\n\n-   **Rule-Out Decision (Negative Test):** A negative result is used to \"rule out\" a diagnosis. The efficacy of this is measured by the NPV. Our calculated $\\text{NPV}$ is $0.9694$. This signifies that if a patient tests negative, there is a $96.94\\%$ probability that they do not have ROM. In our cohort of $100$, out of approximately $39$ negative tests ($39.2$), $38$ are true negatives and only about $1$ ($1.2$) is a false negative. The exceptionally high NPV provides strong assurance that a negative result accurately excludes ROM, allowing the clinician to confidently discharge the patient or avoid unnecessary interventions, thereby improving resource allocation and reducing iatrogenic risks.\n\nIn conclusion, for a patient population with a high pretest probability of ROM ($0.60$), the PAMG-1 test demonstrates excellent clinical utility for both confirming (ruling in) and excluding (ruling out) the diagnosis.",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.9671 & 0.9694 \\end{pmatrix}}$$"
        },
        {
            "introduction": "Once a diagnosis of prelabor rupture of membranes is established, the focus shifts to risk mitigation, a key element of which is preventing neonatal Group B Streptococcus (GBS) disease. This practical exercise requires you to apply a standard, evidence-based antibiotic prophylaxis regimen . You will calculate the total drug dosage administered over a specific clinical timeframe and, more importantly, assess whether the administration meets the criteria for 'adequate prophylaxis,' directly linking pharmacokinetic principles to a crucial patient safety outcome.",
            "id": "4497490",
            "problem": "A patient at term with prelabor rupture of membranes (PROM) presents in early labor with unknown Group B Streptococcus (GBS) status. Intrapartum antibiotic prophylaxis with intravenous penicillin G is initiated upon admission. The standard dosing regimen used is a loading dose of $5$ million units followed by $2.5$ million units every $4$ hours until delivery. Assume dosing is administered at $t=0$ hours (loading dose) and then at $t=4$ hours and $t=8$ hours, with delivery occurring at $t=10$ hours. Using the foundational clinical principles that (i) intrapartum GBS prophylaxis aims to maintain bactericidal maternal and fetal serum and amniotic fluid concentrations through repeated dosing at fixed intervals, and (ii) adequate prophylaxis for neonatal protection is defined by the Centers for Disease Control and Prevention (CDC) as at least $4$ hours of appropriate intravenous antibiotics before delivery, compute the total penicillin G dose administered over the $10$ hours of labor. Then, based on this timing and definition, reason whether the prophylaxis is adequate for neonatal protection, explicitly justifying your conclusion from first principles.\n\nExpress the final numeric answer as the total dose in million units. No rounding is required, but your final numeric response must be a single number that represents million units.",
            "solution": "The problem will be validated by first extracting the given information and then assessing its scientific grounding, consistency, and completeness.\n\n**Step 1: Extract Givens**\n- Patient condition: Term pregnancy, prelabor rupture of membranes (PROM), in early labor.\n- Group B Streptococcus (GBS) status: Unknown.\n- Intervention: Intrapartum antibiotic prophylaxis with intravenous penicillin G, initiated on admission.\n- Dosing regimen:\n    - Loading dose: $5$ million units.\n    - Maintenance dose: $2.5$ million units every $4$ hours until delivery.\n- Timeline:\n    - Loading dose administered at $t=0$ hours.\n    - Maintenance doses administered at $t=4$ hours and $t=8$ hours.\n    - Delivery occurs at $t=10$ hours.\n- Foundational Principles:\n    - (i) Prophylaxis aims to maintain bactericidal concentrations through repeated dosing.\n    - (ii) Definition of adequate prophylaxis for neonatal protection (CDC): at least $4$ hours of appropriate intravenous antibiotics before delivery.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding**: The problem describes a standard-of-care clinical scenario in obstetrics. The use of penicillin G for GBS prophylaxis, the specified dosing regimen ($5$ million units load, $2.5$ million units every $4$ hours), and the definition of adequate prophylaxis (at least $4$ hours prior to delivery) are all consistent with established guidelines from the Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG). The problem is scientifically and factually sound.\n- **Well-Posed**: The problem provides all necessary information to calculate the total dose of penicillin G administered and to evaluate the adequacy of the prophylaxis based on the explicit definition provided. The questions are clear and a unique, stable solution can be determined.\n- **Objective**: The problem is stated using precise, objective clinical terminology. It is free of ambiguity, subjective claims, or opinion.\n\n**Step 3: Verdict and Action**\nThe problem is valid as it is scientifically grounded, well-posed, objective, and self-contained. A solution will be provided.\n\n**Solution Derivation**\n\nThe problem requires two parts: first, the calculation of the total dose of penicillin G administered, and second, an assessment of whether the prophylaxis was adequate for neonatal protection based on the provided definition.\n\n**Part 1: Calculation of Total Administered Dose**\n\nLet $D_{total}$ represent the total dose of penicillin G administered in million units. The dosing schedule is explicitly given.\nA loading dose, $D_L$, is given at time $t=0$ hours.\n$D_L = 5$ million units.\n\nMaintenance doses, $D_M$, are administered every $4$ hours.\n$D_M = 2.5$ million units.\n\nThe timeline of administration is as follows:\n- At $t=0$ hours, the loading dose is given: $5$ million units.\n- At $t=4$ hours, the first maintenance dose is given: $2.5$ million units.\n- At $t=8$ hours, the second maintenance dose is given: $2.5$ million units.\n\nThe next scheduled maintenance dose would be at $t=12$ hours. However, delivery occurs at $t=10$ hours, which is before the next dose is due. Therefore, no further doses are administered after the one at $t=8$ hours.\n\nThe total dose is the sum of all administered doses:\n$D_{total} = (\\text{Dose at } t=0) + (\\text{Dose at } t=4) + (\\text{Dose at } t=8)$\n$D_{total} = 5 + 2.5 + 2.5$\n$D_{total} = 10$ million units.\n\n**Part 2: Assessment of Prophylaxis Adequacy**\n\nThe adequacy of prophylaxis is to be judged based on the explicit criterion provided: \"at least $4$ hours of appropriate intravenous antibiotics before delivery.\"\n\nLet $t_{start}$ be the time the first dose of antibiotics was administered, and let $t_{delivery}$ be the time of delivery.\nFrom the problem statement:\n$t_{start} = 0$ hours.\n$t_{delivery} = 10$ hours.\n\nThe total duration of antibiotic prophylaxis, $\\Delta t$, is the time elapsed from the initiation of therapy to the moment of delivery.\n$\\Delta t = t_{delivery} - t_{start}$\n$\\Delta t = 10 \\text{ hours} - 0 \\text{ hours} = 10 \\text{ hours}$.\n\nThe criterion for adequate prophylaxis is that this duration, $\\Delta t$, must be greater than or equal to $4$ hours.\nWe must check if $\\Delta t \\ge 4$ hours.\nSubstituting the calculated value of $\\Delta t$:\n$10 \\text{ hours} \\ge 4 \\text{ hours}$.\n\nThis inequality is true. Since the duration of prophylaxis ($10$ hours) exceeds the minimum required duration ($4$ hours), the prophylaxis is considered adequate for neonatal protection according to the provided CDC definition. The first foundational principle—that repeated dosing maintains bactericidal concentrations—provides the pharmacological rationale for the regimen, but the determination of adequacy rests solely on the time-based criterion given in the second principle. The patient received the first dose of penicillin G a full $10$ hours before delivery, satisfying the definition of adequacy.",
            "answer": "$$\\boxed{10}$$"
        },
        {
            "introduction": "Modern obstetrics often involves navigating complex decisions where competing risks must be balanced according to patient preferences. This advanced practice introduces a formal method for tackling such dilemmas: Expected Utility Theory. By constructing a decision tree for managing term prelabor rupture of membranes , you will learn to quantify the trade-offs between immediate induction and expectant management, illuminating how to integrate clinical evidence with patient-specific values to facilitate true shared decision-making.",
            "id": "4497545",
            "problem": "A nulliparous patient at term with prelabor rupture of membranes is clinically stable, afebrile, with reassuring fetal status. Two management strategies are under consideration over a fixed decision horizon of $48$ hours: immediate induction of labor and expectant management with close monitoring. For the purpose of decision analysis, consider two adverse outcomes relevant to these strategies over this horizon: clinically significant infection (maternal intraamniotic infection or neonatal sepsis composite) and delivery by cesarean section.\n\nAssume the following empirically plausible probabilities conditioned on the chosen strategy:\n- Under induction: probability of infection $p_{I} = 0.06$, probability of cesarean $q_{I} = 0.21$.\n- Under expectant management: probability of infection $p_{E} = 0.12$, probability of cesarean $q_{E} = 0.18$.\n\nAdopt Expected Utility Theory (EUT) and the linearity of expectation for additive outcomes: assign a patient-specific disutility $u_{I} > 0$ to infection and $u_{C} > 0$ to cesarean. If both outcomes occur, the total disutility is the sum $u_{I} + u_{C}$. Let the patient’s preference be represented by the ratio $r = u_{C}/u_{I}$, with absolute scale irrelevant for choice between strategies. All other outcomes are assigned zero disutility.\n\nUsing only fundamental probability laws and EUT’s additive structure, derive the indifference condition between strategies and compute the threshold preference ratio $r^{\\ast}$ at which the patient is indifferent between induction and expectant management. Report $r^{\\ast}$ as a dimensionless number rounded to four significant figures. No percentage signs are permitted; probabilities and the final value must be expressed as decimals or pure numbers without units.",
            "solution": "The problem is first subjected to validation.\n\n### Step 1: Extract Givens\n- **Patient Cohort**: Nulliparous patient at term with prelabor rupture of membranes.\n- **Decision Horizon**: Fixed at $48$ hours.\n- **Management Strategies**: 1) Immediate Induction of Labor (Strategy I); 2) Expectant Management (Strategy E).\n- **Adverse Outcomes**: Infection (maternal or neonatal composite), and Cesarean Section.\n- **Probabilities for Induction (I)**:\n  - Probability of infection: $p_{I} = 0.06$.\n  - Probability of cesarean: $q_{I} = 0.21$.\n- **Probabilities for Expectant Management (E)**:\n  - Probability of infection: $p_{E} = 0.12$.\n  - Probability of cesarean: $q_{E} = 0.18$.\n- **Decision Framework**: Expected Utility Theory (EUT).\n- **Disutilities**:\n  - $u_{I} > 0$ for infection.\n  - $u_{C} > 0$ for cesarean section.\n  - $u_{I} + u_{C}$ if both outcomes occur (additive disutility).\n  - $0$ for all other outcomes.\n- **Preference Ratio**: $r = u_{C}/u_{I}$.\n- **Objective**: Compute the indifference preference ratio $r^{\\ast}$ at which the patient is indifferent between the two strategies. The result must be a dimensionless number rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientifically Grounded**: The problem is grounded in a common clinical scenario in obstetrics (management of term prelabor rupture of membranes). The management options, outcomes of interest, and the range of probabilities are consistent with published medical literature. The application of Expected Utility Theory is a standard methodology in medical decision analysis. The problem is scientifically and factually sound.\n2.  **Well-Posed**: The problem is well-posed. It provides all necessary probabilities and defines the structure of the utility function required to solve the problem. The question asks for the condition of indifference, which leads to a unique algebraic solution for the preference ratio. The structure of the disutility function, stated as additive, is key. The expected disutility is defined via linearity of expectation, meaning $E[u_{I}X_{I} + u_{C}X_{C}] = u_{I}E[X_{I}] + u_{C}E[X_{C}] = u_{I}P(\\text{Infection}) + u_{C}P(\\text{Cesarean})$, where $X_{I}$ and $X_{C}$ are indicator variables for the respective outcomes. This formulation correctly bypasses any need to know the joint probability of both events occurring, thus avoiding ambiguity or an underspecified setup.\n3.  **Objective**: The problem is stated in precise, quantitative, and objective language, free of subjective claims or bias.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. It is self-contained, scientifically sound, and well-posed. A complete solution will be provided.\n\n### Solution Derivation\nThe objective is to find the preference ratio $r^{\\ast} = u_{C}/u_{I}$ at which a patient is indifferent between immediate induction of labor (Strategy I) and expectant management (Strategy E). Indifference occurs when the expected disutility of both strategies is equal.\n\nLet $U$ be the total disutility. The problem states that the disutility is additive for the two adverse outcomes: infection and cesarean section. For any given strategy, let $P(\\text{inf})$ be the probability of infection and $P(\\text{cs})$ be the probability of a cesarean section. The model for total disutility is $u_I$ for infection, $u_C$ for a cesarean, and $u_I + u_C$ if both occur. This can be modeled using indicator variables. Let $X_{inf}$ be an indicator variable that is $1$ if infection occurs and $0$ otherwise, and let $X_{cs}$ be an indicator variable for a cesarean section. The total disutility is $U = u_I X_{inf} + u_C X_{cs}$.\n\nBy the linearity of expectation, the expected disutility $E[U]$ is:\n$$E[U] = E[u_I X_{inf} + u_C X_{cs}] = u_I E[X_{inf}] + u_C E[X_{cs}]$$\nThe expectation of an indicator variable is the probability of the event it indicates. Therefore:\n$$E[U] = u_I P(\\text{inf}) + u_C P(\\text{cs})$$\nThis formula holds regardless of whether the events of infection and cesarean section are independent.\n\nWe apply this formula to each management strategy.\n\nFor Strategy I (Immediate Induction), the given probabilities are $p_{I}$ for infection and $q_{I}$ for cesarean. The expected disutility, $E[U_I]$, is:\n$$E[U_I] = u_{I} p_{I} + u_{C} q_{I}$$\n\nFor Strategy E (Expectant Management), the given probabilities are $p_{E}$ for infection and $q_{E}$ for cesarean. The expected disutility, $E[U_E]$, is:\n$$E[U_E] = u_{I} p_{E} + u_{C} q_{E}$$\n\nThe indifference condition is defined by the equality of the expected disutilities:\n$$E[U_I] = E[U_E]$$\nSubstituting the expressions for each strategy:\n$$u_{I} p_{I} + u_{C} q_{I} = u_{I} p_{E} + u_{C} q_{E}$$\n\nTo find the preference ratio $r = u_{C}/u_{I}$, we rearrange the equation to isolate terms involving $u_{C}$ and $u_{I}$:\n$$u_{C} q_{I} - u_{C} q_{E} = u_{I} p_{E} - u_{I} p_{I}$$\nFactor out $u_{C}$ and $u_{I}$:\n$$u_{C} (q_{I} - q_{E}) = u_{I} (p_{E} - p_{I})$$\nSince the problem states $u_{I} > 0$, we can divide by $u_{I}$ without loss of generality.\n$$\\frac{u_{C}}{u_{I}} (q_{I} - q_{E}) = (p_{E} - p_{I})$$\nBy definition, $r = u_{C}/u_{I}$. At the point of indifference, $r = r^{\\ast}$:\n$$r^{\\ast} (q_{I} - q_{E}) = (p_{E} - p_{I})$$\nThe term $(q_{I} - q_{E})$ is the difference in cesarean risk, and $(p_{E} - p_{I})$ is the difference in infection risk. We can solve for $r^{\\ast}$:\n$$r^{\\ast} = \\frac{p_{E} - p_{I}}{q_{I} - q_{E}}$$\n\nNow, we substitute the given numerical values:\n$p_{I} = 0.06$\n$q_{I} = 0.21$\n$p_{E} = 0.12$\n$q_{E} = 0.18$\n\nThe calculation for $r^{\\ast}$ is:\n$$r^{\\ast} = \\frac{0.12 - 0.06}{0.21 - 0.18} = \\frac{0.06}{0.03} = 2$$\nThe result is a dimensionless ratio. The problem requires the answer to be reported to four significant figures. An exact integer $2$ is represented as $2.000$ to meet this requirement.\n\nThis threshold value $r^{\\ast} = 2.000$ means that a patient is indifferent between the two strategies if their disutility for a cesarean section is exactly twice their disutility for an infection. If their preference ratio $r > 2$, they would prefer expectant management to minimize the risk of a cesarean. If $r < 2$, they would prefer induction to minimize the risk of infection.",
            "answer": "$$\\boxed{2.000}$$"
        }
    ]
}